Atriance and bone marrow transplant Patient Reports February 12, 2012

Atriance Side Effects Report #5712854-7
Atriance side effect was reported by a Consumer or non-health professional from DENMARK on Apr 15, 2008. Male patient, 18 years of age, weighting 165.3 lb, was diagnosed with leukaemia, bone marrow transplant  and was treated with Atriance. After drug was administered, patient experienced the following side effects: ataxia , bladder disorder, bone marrow transplant , coordination abnormal, csf protein increased, dysaesthesia, dyspraxia, monoplegia. Atriance dosage: 650MGM2 PER DAY. During the same period patient was treated with FLUDARABINE PHOSPHATE, CYTOSAR, METHOTREXATE, AMSACRINE, DAUNOXOME, CRANIAL IRRADIATION. Patient was hospitalized and became disabled. Patient recovered.